EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Updates on ankylosing spondylitis: pathogenesis and therapeutic agents

Se Hee Kim iD, Sang-Hoon Lee iD

Journal of Rheumatic Diseases · 01.10.2023 · 30 (4) · 220-233

DOI: 10.4078/jrd.2023.0041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Rheumatic Diseases, online erschienen am 06.09.2023. Verfasst von Se Hee Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seou…. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ankylosing spondylitis (AS) is an autoinflammatory disease that manifests with the unique feature of enthesitis. Gut microbiota, HLA-B*27, and biomechanical stress mutually influence and interact resulting in setting off a flame of inflammation. In the HLA-B*27 positive group, dysbiosis in the gut environment disrupts the barrier to exogenous bacteria or viruses. Additionally, biomechanical stress induces inflammation through enthesial resident or gut-origin immune cells. On this basis, innate and adaptive immunity can propagate inflammation and lead to chronic disease. Finally, bone homeostasis is regulated by cytokines, by which the inflamed region is substituted into new bone. Agents that block cytokines are constantly being developed to provide diverse therapeutic options for preventing the progression of inflammation. In addition, some antibodies have been shown to distinguish disease selectively, which support the involvement of autoimmune immunity in AS. In this review, we critically analyze the complexity and uniqueness of the pathogenesis with updates on the findings of immunity and provide new information about biologics and biomarkers.

Schlagwörter

Stichwörter der Autor:innen

Adaptive immunityBiological productsEnthesopathyGastrointestinal microbiomeHereditary autoinflammatory diseases

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.

ORCID-Profile: Se Hee Kim, Sang-Hoon Lee

Zitieren

APA

Kim, S. H., & Lee, S. H. (2023). Updates on ankylosing spondylitis: pathogenesis and therapeutic agents. Journal of Rheumatic Diseases, 30(4), 220-233. https://doi.org/10.4078/jrd.2023.0041

Vancouver

Kim SH, Lee SH. Updates on ankylosing spondylitis: pathogenesis and therapeutic agents. Journal of Rheumatic Diseases. 2023;30(4):220-233. doi:10.4078/jrd.2023.0041

BibTeX
@article{Kim2023,
  author = {Kim, Se Hee and Lee, Sang-Hoon},
  title = {Updates on ankylosing spondylitis: pathogenesis and therapeutic agents},
  journal = {Journal of Rheumatic Diseases},
  year = {2023},
  volume = {30},
  number = {4},
  pages = {220--233},
  doi = {10.4078/jrd.2023.0041}
}
Kostenlos starten →